ACRE Announces Strategic Partnership with RELIFE to Support UK Aesthetic Distribution

ACRE has announced a new strategic partnership with RELIFE, supporting the management and distribution of its aesthetic portfolio across the UK.

The partnership marks an important development in ACRE’s role within the UK aesthetics supply chain, extending beyond its traditional pharmacy distribution model.

As part of the agreement, ACRE will hold RELIFE’s aesthetic stock within its regulated warehouse and manage the portfolio from end to end — from receipt and storage through to fulfilment and onward distribution to RELIFE’s appointed pharmacy distributors.

RELIFE and the Menarini Group

RELIFE is the aesthetic arm of the Menarini Pharmaceutical Group, the leading Italian pharmaceutical company globally. The Menarini Group has a heritage spanning more than 130 years, operating across a wide range of healthcare areas.

Its presence in aesthetics comes under the umbrella of RELIFE, a Menarini Business Unit focused on developing innovative skin treatments through scientific research and collaboration with healthcare professionals.

ACRE expands its role within the UK aesthetics supply chain

In addition to its pre-wholesale responsibilities, ACRE will also operate as one of RELIFE’s appointed pharmacy distributors, supplying products directly to eligible healthcare professionals.

This is the first time ACRE has undertaken a pre-wholesale role with a manufacturer, reflecting the continued development of its infrastructure, expertise and position within the UK aesthetics market.

Backed by more than 25 years of pharmaceutical expertise through its parent company, CST Pharma Ltd, ACRE provides a strong foundation of expertise in regulated pharmaceutical supply, warehousing and fulfilment.

Bob Melville, Director and Co-Founder at ACRE, said:

“RELIFE by the Menarini Group represents an exciting new chapter for ACRE. It is a significant vote of confidence in our infrastructure and expertise, and we are proud to be trusted with this responsibility. Our role will be to ensure RELIFE’s products are securely managed and efficiently supplied to its network of appointed pharmacy distributors, while maintaining the high standards of regulatory compliance and responsible supply that underpin everything we do at ACRE.”

Under the new agreement, ACRE will work alongside Menarini’s existing network of appointed pharmacy distributors, providing the central stockholding and fulfilment infrastructure required to support the UK market.

Fergus Gallagher, Head of RELIFE Business Unit UK & Ireland, said:

“We are delighted to partner with ACRE in this new capacity. The partnership will support the efficient management and distribution of our aesthetic portfolio across the UK, while enabling us to continue working closely with our network of appointed pharmacy distributors.”

A broader role for ACRE in UK aesthetics

The agreement reflects ACRE’s continued growth and diversification within the aesthetics sector, expanding its role from specialist pharmacy distribution into a broader supply-chain partner for manufacturers.

The new partnership brings together RELIFE’s aesthetic portfolio and ACRE’s regulated warehousing, fulfilment and pharmaceutical distribution infrastructure, supporting the efficient supply of aesthetic products across the UK.